• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InflaRx N.V. - Common Stock (NQ:IFRX)

2.279 +0.009 (+0.40%)
Streaming Delayed Price Updated: 2:49 PM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 350,688
Open 2.280
Bid (Size) 2.270 (600)
Ask (Size) 2.280 (1,600)
Prev. Close 2.270
Today's Range 2.240 - 2.370
52wk Range 0.7984 - 2.949
Shares Outstanding 44,203,763
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
InflaRx Announces Participation in September Investor Conferences
August 20, 2026
From InflaRx N.V.
Via GlobeNewswire
InflaRx (NASDAQ:IFRX) Tumbles After Q2 Results Miss Estimates ↗
August 06, 2026
Via Chartmill

Performance

YTD
+109.1%
+109.1%
1 Month
+34.9%
+34.9%
3 Month
-4.2%
-4.2%
6 Month
+144.7%
+144.7%
1 Year
+127.9%
+127.9%

More News

Read More
News headline image
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
August 06, 2026
From InflaRx N.V.
Via GlobeNewswire
News headline image
InflaRx to Report Second Quarter 2026 Results on August 6, 2026
July 30, 2026
From InflaRx N.V.
Via GlobeNewswire
News headline image
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
June 30, 2026
From InflaRx N.V.
Via GlobeNewswire
IFRX Stock Soars Pre-Market After Experimental Drug Shows Promise In Treating Chronic Skin Diseases ↗
November 10, 2025
Via Stocktwits
News headline image
InflaRx Investor Update: Izicopan Set to Take Center Stage in AAV and Renal Disease Pipeline ↗
May 08, 2026
Via MarketBeat
News headline image
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
May 08, 2026
From InflaRx N.V.
Via GlobeNewswire
News headline image
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
May 06, 2026
From InflaRx N.V.
Via GlobeNewswire
News headline image
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May 06, 2026
From InflaRx N.V.
Via GlobeNewswire
Friday's session: top gainers and losers ↗
April 17, 2026
Via Chartmill
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
November 21, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
November 18, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 18, 2025
Via Benzinga
News headline image
Is InflaRx NV Gaining or Losing Market Support? ↗
November 14, 2025
Via Benzinga
News headline image
These stocks have an unusual volume in today's session ↗
November 12, 2025
Via Chartmill
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
November 11, 2025
Via Chartmill
News headline image
Earnings Season: Synergy CHC (NASDAQ: SNYR) FOCUSfactor® Beverage – Eyes $100M+ in 2026 – More Stocks Reporting Inside
November 10, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session. ↗
November 10, 2025
Via Chartmill
News headline image
These stocks are the most active in today's session ↗
November 10, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
November 10, 2025
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
November 10, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
November 10, 2025
Via Benzinga
News headline image
Why Viasat Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗
November 10, 2025
Via Benzinga
News headline image
What's going on in today's after hours session ↗
November 07, 2025
Via Chartmill

Frequently Asked Questions

Is InflaRx N.V. - Common Stock publicly traded?
Yes, InflaRx N.V. - Common Stock is publicly traded.
What exchange does InflaRx N.V. - Common Stock trade on?
InflaRx N.V. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for InflaRx N.V. - Common Stock?
The ticker symbol for InflaRx N.V. - Common Stock is IFRX on the Nasdaq Stock Market
What is the current price of InflaRx N.V. - Common Stock?
The current price of InflaRx N.V. - Common Stock is 2.279
When was InflaRx N.V. - Common Stock last traded?
The last trade of InflaRx N.V. - Common Stock was at 08/28/26 02:49 PM ET
What is the market capitalization of InflaRx N.V. - Common Stock?
The market capitalization of InflaRx N.V. - Common Stock is 100.74M
How many shares of InflaRx N.V. - Common Stock are outstanding?
InflaRx N.V. - Common Stock has 101M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap